Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
0.7350
-0.0037 (-0.50%)
At close: Aug 28, 2026, 4:00 PM EDT
0.7201
-0.0149 (-2.03%)
After-hours: Aug 28, 2026, 7:58 PM EDT

Daré Bioscience Stock Forecast

DARE's stock price has decreased by -63.61% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 3 analysts polled by S&P Global, Daré Bioscience stock has a consensus rating of "Strong Buy" and an average price target of $8.33. The average 1-year stock price forecast is 1,033.33% higher than the current stock price, while the lowest is $5.00 (+580.27%) and the highest is $12 (+1,532.65%).

Price Target: $8.33 (+1,033.33%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$5.00$8.33$8.00$12
Change+580.27%+1033.3%+988.44%+1532.7%

Analyst Ratings

The average analyst rating for Daré Bioscience stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingDec '25Feb '26Mar '26Apr '26May '26Aug '26
Strong Buy322222
Buy111111
Hold000000
Sell000000
Strong Sell000000
Total433333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Maintains
$8
BuyMaintains$8+988.44%Aug 15, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$12
BuyReiterates$12+1,532.65%Aug 14, 2026

Financial Forecast

Revenue This Year
2.72M
from 1.03M
Increased by 163.80%
Revenue Next Year
8.86M
from 2.72M
Increased by 226.14%
EPS This Year
-0.77
from -1.20
EPS Next Year
-0.42
from -0.77
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-10.00M2.81M9.78K1.03M2.72M
Revenue Growth
---71.92%-99.65%10,429.36%163.80%
Gross Profit
-100.00K-20.14M-18.83M9.78K734.39K1.60M
Gross Margin
--201.42%-670.62%100.00%71.29%59.00%
Operating Income
-39.07M-31.39M-30.74M-23.45M-13.55M-13.07M
Net Income
-38.70M-30.95M-30.16M-4.05M-13.40M-12.99M
EPS
-----1.20-0.77
Free Cash Flow
-15.28M-6.80M-27.18M-7.62M-4.81M129.39M
No. Analysts
-----3
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High7.1M
Avg2.7M
Low340,000

Revenue Growth

Revenue Growth202620272028
High
593.4%
Avg
163.8%
Low
-67.0%

EPS Forecast

EPS202620272028
High-0.43
Avg-0.77
Low-0.97

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-